The Clinical Pharmacology & Pharmacogenomics Fellowship Training Program at OSUWMC offers rigorous, personalized training that combines didactic, research, and clinical experience. Our fellowship training program is 1 of 13 programs accredited by the American Board of Clinical Pharmacology (ABCP). Participants who complete our fellowship training program may be eligible for ABCP board certification in Clinical Pharmacology or Applied Pharmacology. Successful completion of our fellowship training program, however, does not guarantee ABCP board eligibility (i.e., only the ABCP Credentials Committee determines ABCP board eligibility). Please see www.abcp.net for more details.
Our fellowship training program has two tracks: Physician and Non-Physician. The physician track is only available for trainees licensed to practice medicine in Ohio.
The training period is typically of two years duration and focuses on learning through mentored research and/or clinical experiences. Training requirements are tailored to fit individual backgrounds and career aspirations. Those with significant research, clinical, and/or professional experience may require less time to complete the fellowship as their previous education, experience, and achievements may satisfy certain fellowship completion requirements. Co-mentorship with OSU fellowship faculty is required. Part-time and remote-site options may be considered.
Fellows typically complete a Master's degree during the first year of the fellowship. The options for Master's programs at OSU include an online Masters of Science (MS) in Pharmacology, a Masters of Public Health (MPH), or a Masters of Health Administration (MHA). Those with dual doctoral degrees and those who have completed a graduate degree in Pharmacy or Pharmacology may not be required to complete a Master's degree as part of the fellowship-completion requirements.
Fellowship positions are highly competitive, and our fellowship training program is limited to two trainees per academic year. The Clinical Pharmacology & Pharmacogenomics Fellowship Training Program at OSUWMC does not currently have funding available for fellowship stipends or tuition support. Candidates must obtain their own financial support (e.g., scholarships, fellowships, stipends, or concurrent employment) in order to participate in our fellowship training program. Examples of financial support for previous fellowship trainees have included the National Institutes of Health, the American Heart Association, PHRMA, and pharmaceutical and biomedical companies (e.g., Merck, Pfizer, Purdue Pharma). Other trainees have procured support through employment as a Graduate Research Associate or Postdoctoral Researcher at OSU or other universities/institutions.
A peer-reviewed article providing an overview and examples of the fellowship-completion requirements for fellowship training program can be found at PubMed Article: OSU Clinical Pharmacology Fellowship.
Director: Joseph Kitzmiller, MD PhD FCP
Pharmacogenomics Rotation Director: Wolfgang Sadee, Dr rer Nat
Pharmaco-Analytics Rotation Director: Mitch Phelps, PhD
Pediatrics Rotation Director: John Mahan, MD FAAP
Education Director: Marjorie Neidecker PhD RN CCRP
- have a U.S. doctoral degree (e.g., MD, PhD, PharmD, ScD) or equivalent (e.g., MBBS, MBCH).
- be a U.S. citizen or permanent resident. Non-U.S. citizens may apply, but must have guaranteed visa sponsorship.
Applications are accepted on a rolling basis. Please see the "Application Checklist and Submission Instructions' below for specific details.
Prior to submitting application materials, potential applicants are strongly encouraged to communicate with the Fellowship Director (Dr. Joseph Kitzmiller) in order to discuss their appropriateness for the fellowship program. The purpose of the communication is to determine the applicant's research interests, their potential for acceptance into the fellowship training program, and to determine potential mentors, sponsors and research project(s).
Please direct your questions to Dr. Joseph Kitzmiller at email@example.com